Position in XGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$420,000
-$613,600 QoQ
Shares Held
140,000
-17.6% QoQ
Ownership
0.579%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Massar Capital Management, LP holds $773,889 across 3 Diagnostics & Research names. XGN ranks #1 (54.3% of the industry book) .
All Filings in XGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $420,000 | 140,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,033,600 | 170,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,868,300 | 170,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,186,600 | 170,000 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $74,815 | 20,840 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||